Advancing Infectious Disease Research With The QX700 ddPCR System

In the high-stakes fields of virology and immunology, the transition from preclinical research to clinical trials hinges on the ability to extract meaningful data from limited, high-value samples. Traditional diagnostic workflows often face bottlenecks due to high volume requirements and lengthy processing times, which can stall the pace of drug discovery. By integrating advanced digital PCR technology, researchers can now achieve precise quantification and high-level multiplexing—targeting up to 28 distinct markers—from as little as five microliters of fluid.

This shift toward automated, sensitive instrumentation significantly reduces turnaround times, cutting extraction processes from hours to minutes. Such scalability not only preserves precious clinical specimens but also provides a robust framework for verifying NGS findings with confidence. Embracing these high-throughput capabilities allows labs to maintain rigorous patient safety standards while accelerating the identification of new therapeutic targets. Explore how these technical advancements are redefining efficiency in vaccine development.